COM_SMA_Spinraza_Promo_Page_2022_EN-AUDIENCE_RESOURCE_SET

COM_SMA_Spinraza_Promo_Page_2022_EN-CONTENT_TYPE_RESOURCE_SET

COM_SMA_Spinraza_Promo_Page_2022_EN-FORMAT_RESOURCE_SET

COM_SMA_Spinraza_Promo_Page_2022_EN-MARKET_RESOURCE_SET

COM_SMA_Spinraza_Promo_Page_2022_EN-PRODUCT_RESOURCE_SET

COM_SMA_Spinraza_Promo_Page_2022_EN-PROMO_TYPE_RESOURCE_SET

COM_SMA_Spinraza_Promo_Page_2022_EN-REGION_RESOURCE_SET

COM_SMA_Spinraza_Promo_Page_2022_EN-THERAPEUTIC_AREA_RESOURCE_SET

COM_SMA_Spinraza_Promo_Page_2022_EN

Products

Spinraza Bubble Intro 

DotGrid_Spinraza_Dark Backgroung Mobile_340x408 

SPINRAZA™ offers solutions for eligible patients regardless of age/disease stage, with real-world evidence in more than 13,000 patients.<sup>1-3</sup>

SPINRAZA™

##### The SPINRAZA Summary of product characteristics (SmPC) was recently updated featuring the inclusion of new Real-world evidence for adult patients, removal of the black triangle for additional monitoring requirements and recommendations for delayed or missed doses.

You may be interested in

Spinraza